Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms-Reference-Cited by-同舟云学术

Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms

Published:2025-04-17 Issue:1 Volume:15 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Quinn Colin H.,Julson Janet R.,Erwin Michael H.,Markert Hooper R.,Bownes Larua V.,Stewart Jerry E.,Shirley Sorina,Yoon Karina J.,Aye Jamie M.,Markert James M.,Beierle Elizabeth A.

Funder

National Institute of Health

National Cancer Institute

Open Hands Overflowing Hearts

Sid Strong Foundation

Elaine Roberts Foundation

Kaul Pediatric Research Foundation

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-025-98588-7.pdf

Reference34 articles.

1. Sarvida, M. E. & O’Dorisio, M. S. Neuroendocrine tumors in children and young adults: rare or not so rare. Endocrinol. Metab. Clin. North Am. 40(1), 65–80 (2011).

2. Zhuge, Y. et al. Pediatric intestinal foregut and small bowel solid tumors: A review of 105 cases. J. Surg. Res. 156(1), 95–102 (2009).

3. Dasari, A. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3(10), 1335–1342 (2017).

4. Navalkele, P. et al. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: Nine standard SEER registries, 1975–2006. Pediatr. Blood Cancer 56(1), 50–57 (2011).

5. Haddad, T., Fard-Esfahani, A. & Vali, R. A review of pediatric neuroendocrine tumors, their detection, and treatment by radioisotopes. Nucl. Med. Commun. 42(1), 21–31 (2021).